Chugai Pharmaceutical Co., Ltd.
Symbol: 4519.T
JPX
5436
JPYDzisiejsza cena rynkowa
25.1308
Wskaźnik P/E
0.4474
Wskaźnik PEG
8.94T
Kapitalizacja MRK
- 0.02%
Rentowność DIV
Chugai Pharmaceutical Co., Ltd. (4519-T) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 2787296 | 738982 | 503107 | 471970 | |||||||||||||||||||||
balance-sheet.row.short-term-investments | 1169402 | 280308 | 280938 | 204217 | |||||||||||||||||||||
balance-sheet.row.net-receivables | 1175428 | 320348 | 514283 | 356009 | |||||||||||||||||||||
balance-sheet.row.inventory | 1094030 | 273480 | 292206 | 208838 | |||||||||||||||||||||
balance-sheet.row.other-current-assets | 161328 | 33616 | 26941 | 26844 | |||||||||||||||||||||
balance-sheet.row.total-current-assets | 5218082 | 1366426 | 1336537 | 1063661 | |||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 1670723 | 420701 | 386651 | 352107 | |||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.intangible-assets | 80088 | 19860 | 25141 | 21974 | |||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 80088 | 19860 | 25141 | 21974 | |||||||||||||||||||||
balance-sheet.row.long-term-investments | 10984 | 1254 | -279101 | -201824 | |||||||||||||||||||||
balance-sheet.row.tax-assets | 263786 | 64474 | 65244 | 56287 | |||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 235887 | 59832 | 335286 | 246489 | |||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 2261468 | 566121 | 533221 | 475033 | |||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-assets | 7479550 | 1932547 | 1869758 | 1538694 | |||||||||||||||||||||
balance-sheet.row.account-payables | 353134 | 54234 | 209835 | 152266 | |||||||||||||||||||||
balance-sheet.row.short-term-debt | 6975 | 6975 | 6434 | 6550 | |||||||||||||||||||||
balance-sheet.row.tax-payables | 140811 | 40798 | 98543 | 86312 | |||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 6480 | 6480 | -430 | -490 | |||||||||||||||||||||
Deferred Revenue Non Current | 378 | 378 | 430 | 490 | |||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 20615 | - | - | - | |||||||||||||||||||||
balance-sheet.row.other-current-liab | 729647 | 226977 | 207382 | 168520 | |||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 73820 | 18749 | 21641 | 23255 | |||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 29351 | 6480 | 7675 | 9490 | |||||||||||||||||||||
balance-sheet.row.total-liab | 1163607 | 306966 | 445371 | 350677 | |||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.common-stock | 292808 | 73202 | 73202 | 73202 | |||||||||||||||||||||
balance-sheet.row.retained-earnings | 5765677 | 1488738 | 1293352 | 1054050 | |||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -19740 | -5714 | -10972 | -7457 | |||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 277198 | 69354 | 68805 | 68222 | |||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 6315943 | 1625580 | 1424387 | 1188017 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 7479550 | 1932546 | 1869758 | 1538694 | |||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-equity | 6315943 | 1625580 | 1424387 | 1188017 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 7479550 | - | - | - | |||||||||||||||||||||
Total Investments | 1170656 | 281562 | 1837 | 2393 | |||||||||||||||||||||
balance-sheet.row.total-debt | 36326 | 13455 | 14109 | 16040 | |||||||||||||||||||||
balance-sheet.row.net-debt | -1581568 | -445219 | -208060 | -251713 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 398330 | 325472 | 575875 | 470367 | |||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 2700 | 31740 | 31434 | 30868 | |||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.change-in-working-capital | 50548 | 130634 | -183311 | -83122 | |||||||||||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.other-working-capital | 50548 | 130634 | -183311 | -83122 | |||||||||||||||||||||
cash-flows.row.other-non-cash-items | -66477 | -76520 | -179886 | -138487 | |||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 384301 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -59603 | -74258 | -71239 | -72866 | |||||||||||||||||||||
cash-flows.row.acquisitions-net | 17093 | 19346 | 1048 | 6897 | |||||||||||||||||||||
cash-flows.row.purchases-of-investments | -569376 | -545983 | -519002 | -372264 | |||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 574541 | 546962 | 442919 | 325028 | |||||||||||||||||||||
cash-flows.row.other-investing-activites | -17977 | 15161 | 280 | -5722 | |||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -35455 | -38772 | -145994 | -118927 | |||||||||||||||||||||
cash-flows.row.debt-repayment | -5842 | -7863 | 0 | -9079 | |||||||||||||||||||||
cash-flows.row.common-stock-issued | 171 | 217 | 241 | 322 | |||||||||||||||||||||
cash-flows.row.common-stock-repurchased | -7 | -5 | -5 | -8 | |||||||||||||||||||||
cash-flows.row.dividends-paid | -131188 | -131594 | -138220 | -98644 | |||||||||||||||||||||
cash-flows.row.other-financing-activites | -1954 | -5 | -7657 | 1 | |||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -138841 | -139250 | -145641 | -107408 | |||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 5171 | 3202 | 1939 | 2128 | |||||||||||||||||||||
cash-flows.row.net-change-in-cash | 215177 | 236505 | -45584 | 55420 | |||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 1617894 | 458674 | 222169 | 267753 | |||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 1402717 | 222169 | 267753 | 212333 | |||||||||||||||||||||
cash-flows.row.operating-cash-flow | 384301 | 411326 | 244112 | 279626 | |||||||||||||||||||||
cash-flows.row.capital-expenditure | -59603 | -74258 | -71239 | -72866 | |||||||||||||||||||||
cash-flows.row.free-cash-flow | 324698 | 337068 | 172873 | 206760 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1036075 | 1111367 | 1259946 | 999759 | |||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 334928 | 418358 | 476251 | 338147 | |||||||||||||||||||||
income-statement-row.row.gross-profit | 701147 | 693009 | 783695 | 661612 | |||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.research-development | 173268 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-general-administrative | -6604 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 114150 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-expenses | -1394 | 0 | -2134 | -2540 | |||||||||||||||||||||
income-statement-row.row.operating-expenses | 265960 | 277344 | 250386 | 239715 | |||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 600888 | 695702 | 726637 | 577862 | |||||||||||||||||||||
income-statement-row.row.interest-income | 1411 | 1482 | 182 | 166 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 24 | 27 | 61 | 48 | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 114150 | - | - | - | |||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 8859 | 28156 | -2143 | -2512 | |||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -1394 | 0 | -2134 | -2540 | |||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 8859 | 28156 | -2143 | -2512 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 24 | 27 | 61 | 48 | |||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 4183 | 31740 | -2082 | -2464 | |||||||||||||||||||||
income-statement-row.row.ebitda-caps | 439372 | - | - | - | |||||||||||||||||||||
income-statement-row.row.operating-income | 435189 | 415665 | 533309 | 421897 | |||||||||||||||||||||
income-statement-row.row.income-before-tax | 444048 | 443821 | 531166 | 419385 | |||||||||||||||||||||
income-statement-row.row.income-tax-expense | 117676 | 118349 | 156737 | 116390 | |||||||||||||||||||||
income-statement-row.row.net-income | 326373 | 325472 | 374429 | 302995 |
Często zadawane pytania
Ile wynosi Chugai Pharmaceutical Co., Ltd. (4519.T) aktywów ogółem?
Chugai Pharmaceutical Co., Ltd. (4519.T) całkowite aktywa to 1932547000000.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to 510761000000.000.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.677.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to 197.344.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.315.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.420.
Co to jest Chugai Pharmaceutical Co., Ltd. (4519.T) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi 325472000000.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 13455000000.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 277344000000.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 462863000000.000.